{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:37:31Z","timestamp":1776832651133,"version":"3.51.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,12,25]],"date-time":"2011-12-25T00:00:00Z","timestamp":1324771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00296-011-2316-x","type":"journal-article","created":{"date-parts":[[2011,12,24]],"date-time":"2011-12-24T04:08:18Z","timestamp":1324699698000},"page":"1101-1103","source":"Crossref","is-referenced-by-count":22,"title":["Optic neuritis after infliximab therapy"],"prefix":"10.1007","volume":"33","author":[{"given":"C\u00e9sar","family":"Faillace","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Ricardo Maltez","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joz\u00e9lio Freire","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,25]]},"reference":[{"key":"2316_CR1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","volume":"36","author":"MJ Elliot","year":"1993","unstructured":"Elliot MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsiks P et al (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor \u03b1. Arthritis Rheum 36:1681\u20131690","journal-title":"Arthritis Rheum"},{"key":"2316_CR2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semarthrit.2008.10.002","volume":"39","author":"DE Furst","year":"2010","unstructured":"Furst DE (2010) The risk of infections with biologic therapies for rheumatoid arthritis. Semin Arthritis Rheum 39:327\u2013346","journal-title":"Semin Arthritis Rheum"},{"key":"2316_CR3","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.47.6.1531","volume":"47","author":"BW Oosten van","year":"1996","unstructured":"van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, von Blomberg BM, Woody JN, Hartung HP, Polman CH (1996) Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47:1531\u20131534","journal-title":"Neurology"},{"key":"2316_CR4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00054725-200401000-00004","volume":"10","author":"CW Thomas Jr","year":"2004","unstructured":"Thomas CW Jr, Weinshenker BG, Sandborn WJ (2004) Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn\u2019s disease. Inflamm Bowel Dis 10:28\u201331","journal-title":"Inflamm Bowel Dis"},{"key":"2316_CR5","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/art.21814","volume":"54","author":"IS Shin","year":"2006","unstructured":"Shin IS, Baer AN, Kwon HJ, Papadopoulos EJ, Siegel JN (2006) Guillain-Barr\u00e9 and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum 54:1429\u20131434","journal-title":"Arthritis Rheum"},{"key":"2316_CR6","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","volume":"44","author":"N Mohan","year":"2001","unstructured":"Mohan N, Edwards ET, Cupps TR, Oliverio PJ, Sandberg G, Crayton H, Richert JR, Siegel JN (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44:2862\u20132869","journal-title":"Arthritis Rheum"},{"key":"2316_CR7","first-page":"985","volume":"120","author":"R Foroozan","year":"2002","unstructured":"Foroozan R, Buono LM, Sergott RC, Savino PJ (2002) Retrobulbar optic neuritis associated with infliximab. Arch Ophthalmol 120:985\u2013987","journal-title":"Arch Ophthalmol"},{"key":"2316_CR8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archopht.122.5.793","volume":"122","author":"LJ Mejico","year":"2004","unstructured":"Mejico LJ (2004) Infliximab-associated retrobulbar optic neuritis. Arch Ophthalmol 122:793\u2013794","journal-title":"Arch Ophthalmol"},{"key":"2316_CR9","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.7326\/0003-4819-140-8-200404200-00037-w4","volume":"140","author":"BY Strong","year":"2004","unstructured":"Strong BY, Erny BC, Herzenberg H, Razzeca KJ (2004) Retrobulbar optic neuritis associated with infliximab in a patient with Crohn disease. Ann Intern Med 140:W34","journal-title":"Ann Intern Med"},{"key":"2316_CR10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00417-009-1227-y","volume":"248","author":"JW Chan","year":"2010","unstructured":"Chan JW, Castellanos A (2010) Infliximab and anterior optic neuropathy: case report and review of the literature. Graefes Arch Clin Exp Ophthalmol 248:283\u2013287","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2316_CR11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.crohns.2009.04.001","volume":"3","author":"T Felekis","year":"2009","unstructured":"Felekis T, Katsanos K, Christodoulou D, Asproudis I, Tsianos EV (2009) Reversible bilateral optic neuritis after Infliximab discontinuation in a patient with Crohn\u2019s disease. J Crohns Colitis 3:212\u2013214","journal-title":"J Crohns Colitis"},{"key":"2316_CR12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.crohns.2009.02.007","volume":"3","author":"A Ouakaa-Kchaou","year":"2009","unstructured":"Ouakaa-Kchaou A, Gargouri D, Trojet S, Hefaiedh R, Elloumi H, Kochlef A, Kilani A, Romani M, Kharrat J, Ghorbel A (2009) Retrobulbar optic neuritis associated with infliximab in a patient with Crohn\u2019s disease. J Crohns Colitis 3:131\u2013133","journal-title":"J Crohns Colitis"},{"key":"2316_CR13","first-page":"477","volume":"10","author":"J Pikkel","year":"2008","unstructured":"Pikkel J (2008) Possible link between infliximab and optic neuritis. Isr Med Assoc J 10:477\u2013478","journal-title":"Isr Med Assoc J"},{"key":"2316_CR14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.gcb.2008.01.003","volume":"32","author":"R Hejazi","year":"2008","unstructured":"Hejazi R, Colombel JF, Peyrin-Biroulet L (2008) Retrobulbar optic neuritis during infliximab treatment for ulcerative colitis. Gastroenterol Clin Biol 32:162\u2013163","journal-title":"Gastroenterol Clin Biol"},{"key":"2316_CR15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/qjmed\/hcm060","volume":"100","author":"N Mumoli","year":"2007","unstructured":"Mumoli N, Niccoli G, Scazzeri F, Picchietti S, Greco A, Cei M (2007) Infliximab-induced retrobulbar optic neuritis. QJM 100:531","journal-title":"QJM"},{"key":"2316_CR16","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/ard.2006.066787","volume":"66","author":"I Simsek","year":"2007","unstructured":"Simsek I, Erdem H, Pay S, Sobaci G, Dinc A (2007) Optic neuritis occurring with anti-tumour necrosis factor alpha therapy. Ann Rheum Dis 66:1255\u20131258","journal-title":"Ann Rheum Dis"},{"key":"2316_CR17","first-page":"109","volume":"82","author":"A Bidaguren","year":"2007","unstructured":"Bidaguren A, M\u00fcller-Thyssen A, Blanco A, Mendicute J, Ubeda M (2007) Retrobulbar optic neuritis associated with Infliximab. Arch Soc Esp Oftalmol 82:109\u2013112","journal-title":"Arch Soc Esp Oftalmol"},{"key":"2316_CR18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0181-5512(05)81044-7","volume":"28","author":"TH Tran","year":"2005","unstructured":"Tran TH, Milea D, Cassoux N, Bodaghi B, Bourgeois P, LeHoang P (2005) Optic neuritis associated with infliximab. J Fr Ophtalmol 28:201\u2013204","journal-title":"J Fr Ophtalmol"},{"key":"2316_CR19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4321\/S0365-66912004001200003","volume":"79","author":"G Rebolleda","year":"2004","unstructured":"Rebolleda G (2004) Optic neuritis and infliximab. Arch Soc Esp Oftalmol 79:591","journal-title":"Arch Soc Esp Oftalmol"},{"key":"2316_CR20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/09273948.2010.495814","volume":"18","author":"SY Li","year":"2010","unstructured":"Li SY, Birnbaum AD, Goldstein DA (2010) Optic neuritis associated with adalimumab in the treatment of uveitis. Ocul Immunol Inflamm 18:475\u2013481","journal-title":"Ocul Immunol Inflamm"},{"key":"2316_CR21","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6","volume":"44","author":"WH Robinson","year":"2001","unstructured":"Robinson WH, Genovese MC, Moreland LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44:1977\u20131983","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2316-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-2316-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2316-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:21:35Z","timestamp":1559042495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-2316-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,25]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["2316"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-2316-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,25]]}}}